Grant Lawless

The Impact of Age on Delivered Dose Intensity and Hospitalizations for Febrile Neutropenia in Patients with Intermediate-Grade Non-Hodgkin's Lymphoma Receiving Initial CHOP Chemotherapy: A Risk Factor Analysis

Vicki A. Morrison, Vincent J. Picozzi, Brad Pohlman et al. · Clinical Lymphoma · 2001 · 144 citations

Lymphoid Neoplasia, Intermediate-grade Non-hodgkin, Medicine +8

Benefit Design And Specialty Drug Use

Dana P. Goldman, Geoffrey Joyce, Grant Lawless et al. · Health Affairs · 2006 · 121 citations · Full text

Drug Treatment, Primary Care, Drug Design +18

Delivering adjuvant chemotherapy to women with early-stage breast carcinoma

Brian K. Link, G. Thomas Budd, Elliot Dickman et al. · Cancer · 2001 · 79 citations

Impact of Age and Colony-Stimulating Factor Use on Hospital Length of Stay for Febrile Neutropenia in CHOP-Treated Non-Hodgkin's Lymphoma

Elizabeth A. Chrischilles, David J. Delgado, Bradley S. Stolshek et al. · Cancer Control · 2002 · 77 citations

Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1G93A ALS rat but has adverse side effects

Gretchen M. Thomsen, Mor R. Alkaslasi, Jean‐Philippe Vit et al. · Gene Therapy · 2017 · 43 citations · Full text